MOLLY MCINNIS: Open Payments
NPI 1992316905 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$312 in 16 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $56 · 2025 $312
Food & beverage: $312
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $80 |
| Novo Nordisk Inc | 2 | $38 |
| Lilly USA, LLC | 2 | $37 |
| Astellas Pharma US Inc | 1 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Insulet Corporation | 1 | $19 |
| Neurelis, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Viatris Specialty LLC | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: VRAYLAR, MOUNJARO, Veozah, HETLIOZ, Wegovy, UBRELVY, Omnipod, VALTOCO.
Industry payments across MI — which companies pay providers there.
